norharman has been researched along with brassinin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blanc, S; Colau, D; Colette, D; Dolušić, E; Ferain, T; Fraser, G; Frédérick, R; Frère, JM; Galeni, M; Galleni, M; Larrieu, P; Masereel, B; Moineaux, L; Norberg, B; Pilotte, L; Sapunaric, F; Stroobant, V; Van den Eynde, B; Wouters, J | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
2 other study(ies) available for norharman and brassinin
| Article | Year |
|---|---|
Indol-2-yl ethanones as novel indoleamine 2,3-dioxygenase (IDO) inhibitors.
Topics: Catalytic Domain; Cell Line; Ethane; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Indoles; Models, Molecular; Protein Interaction Domains and Motifs; Structure-Activity Relationship | 2011 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |